{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:38:02Z","timestamp":1787240282304,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-025-03477-9","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:42:44Z","timestamp":1748666564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unlocking the therapeutic potential of lncRNA FENDRR in DCM: novel targets and insights via the miR-296-5p\/HMGA1 axis"],"prefix":"10.1186","volume":"20","author":[{"given":"Lei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunhai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"issue":"3","key":"3477_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","volume":"15","author":"S Paolillo","year":"2019","unstructured":"Paolillo S, Marsico F, Prastaro M, Renga F, Esposito L, De Martino F, et al. Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications. Heart Fail Clin. 2019;15(3):341\u20137.","journal-title":"Heart Fail Clin"},{"issue":"2","key":"3477_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.rce.2019.10.013","volume":"222","author":"A Lorenzo-Almor\u00f3s","year":"2022","unstructured":"Lorenzo-Almor\u00f3s A, Cepeda-Rodrigo JM, Lorenzo \u00d3. Diabetic cardiomyopathy. Rev Clin Esp. 2022;222(2):100\u201311.","journal-title":"Rev Clin Esp"},{"issue":"16","key":"3477_CR3","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jacc.2021.08.026","volume":"78","author":"VR Aroda","year":"2021","unstructured":"Aroda VR, Taub PR, Stanton AM. Diabetes With Cardiomyopathy: At the Juncture of Knowledge and Prevention. J Am Coll Cardiol. 2021;78(16):1599\u2013602.","journal-title":"J Am Coll Cardiol"},{"key":"3477_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.omtn.2023.04.025","volume":"32","author":"R Xie","year":"2023","unstructured":"Xie R, Fan J, Wen J, Jin K, Zhan J, Yuan S, et al. LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathway. Molecular Therapy Nucleic Acids. 2023;32:689\u2013703.","journal-title":"Molecular Therapy Nucleic Acids"},{"issue":"2","key":"3477_CR5","first-page":"693","volume":"35","author":"JZ Li","year":"2021","unstructured":"Li JZ, Jin XH, Zhang FM, Guo QR. Dysregulation of lncRNA NRON in diabetic cardiomyopathy protects against high glucoseinduced cardiomyocyte injury and inflammation. J Biol Regul Homeost Agents. 2021;35(2):693\u20137.","journal-title":"J Biol Regul Homeost Agents"},{"key":"3477_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-981-15-1671-9_10","volume":"1229","author":"L Xia","year":"2020","unstructured":"Xia L, Song M. Role of Non-coding RNA in Diabetic Cardiomyopathy. Adv Exp Med Biol. 2020;1229:181\u201395.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"3477_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-021-01245-2","volume":"20","author":"D Jakubik","year":"2021","unstructured":"Jakubik D, Fitas A, Eyileten C, Jarosz-Popek J, Nowak A, Czajka P, et al. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. Cardiovasc Diabetol. 2021;20(1):55.","journal-title":"Cardiovasc Diabetol"},{"key":"3477_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.655598","volume":"8","author":"Y Guo","year":"2021","unstructured":"Guo Y, Feng X, Wang D, Kang X, Zhang L, Ren H, et al. Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy. Frontiers Cardiovasc Med. 2021;8: 655598.","journal-title":"Frontiers Cardiovasc Med"},{"issue":"2","key":"3477_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.devcel.2012.12.012","volume":"24","author":"P Grote","year":"2013","unstructured":"Grote P, Wittler L, Hendrix D, Koch F, W\u00e4hrisch S, Beisaw A, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013;24(2):206\u201314.","journal-title":"Dev Cell"},{"issue":"10","key":"3477_CR10","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.4161\/rna.26165","volume":"10","author":"P Grote","year":"2013","unstructured":"Grote P, Herrmann BG. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis. RNA Biol. 2013;10(10):1579\u201385.","journal-title":"RNA Biol"},{"issue":"1","key":"3477_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s10020-022-00551-z","volume":"28","author":"X Wang","year":"2022","unstructured":"Wang X, Li Q, He S, Bai J, Ma C, Zhang L, et al. LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation. Molecular Medicine (Cambridge, Mass). 2022;28(1):126.","journal-title":"Molecular Medicine (Cambridge, Mass)"},{"key":"3477_CR12","doi-asserted-by":"crossref","unstructured":"Agwa SHA, Elzahwy SS, El Meteini MS, Elghazaly H, Saad M, Abd Elsamee AM, et al. ABHD4-Regulating RNA Panel: Novel Biomarkers in Acute Coronary Syndrome Diagnosis. Cells. 2021;10(6).","DOI":"10.3390\/cells10061512"},{"key":"3477_CR13","doi-asserted-by":"crossref","unstructured":"Cuesta-Llavona E, Lorca R, Rolle V, Alonso B, Iglesias S, Rodr\u00edguez-Reguero J, et al. Association of the Genetic Variation in the Long Non-Coding RNA FENDRR with the Risk of Developing Hypertrophic Cardiomyopathy. Life (Basel, Switzerland). 2022;12(6).","DOI":"10.3390\/life12060818"},{"issue":"8","key":"3477_CR14","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00210-019-01795-z","volume":"393","author":"J Zhao","year":"2020","unstructured":"Zhao J, Liu B, Li C. Knockdown of long noncoding RNA GAS5 protects human cardiomyocyte-like AC16 cells against high glucose-induced inflammation by inhibiting miR-21-5p-mediated TLR4\/NF-\u03baB signaling. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(8):1541\u20137.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"3477_CR15","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1080\/21655979.2021.2024688","volume":"13","author":"L Fu","year":"2022","unstructured":"Fu L, Zhang J, Lin Z, Li Y, Qin G. CircularRNA circ_0071269 knockdown protects against from diabetic cardiomyopathy injury by microRNA-145\/gasdermin A axis. Bioengineered. 2022;13(2):2398\u2013411.","journal-title":"Bioengineered"},{"issue":"3","key":"3477_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24604","volume":"10","author":"Y Luo","year":"2024","unstructured":"Luo Y, Jiang Y, Zhong T, Li Z, He J, Li X, et al. LncRNA HCG18 affects diabetic cardiomyopathy and its association with miR-9-5p\/IGF2R axis. Heliyon. 2024;10(3): e24604.","journal-title":"Heliyon"},{"issue":"1","key":"3477_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s10020-021-00299-y","volume":"27","author":"LQ Wang","year":"2021","unstructured":"Wang LQ, Zheng YY, Zhou HJ, Zhang XX, Wu P, Zhu SM. LncRNA-Fendrr protects against the ubiquitination and degradation of NLRC4 protein through HERC2 to regulate the pyroptosis of microglia. Molecular Medicine (Cambridge, Mass). 2021;27(1):39.","journal-title":"Molecular Medicine (Cambridge, Mass)"},{"key":"3477_CR18","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.2147\/JIR.S479154","volume":"17","author":"Y Deng","year":"2024","unstructured":"Deng Y, Duan R, Hong Y, Peng Q, Li ZY, Chen XL, et al. Trimethylamine N-Oxide Aggravates Neuro-Inflammation via lncRNA Fendrr\/miR-145-5p\/PXN Axis in Vascular Dementia Rats. J Inflamm Res. 2024;17:7441\u201361.","journal-title":"J Inflamm Res"},{"issue":"10","key":"3477_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2019.194435","volume":"1862","author":"C Garc\u00eda-Padilla","year":"2019","unstructured":"Garc\u00eda-Padilla C, Dom\u00ednguez JN, Ar\u00e1nega AE, Franco D. Differential chamber-specific expression and regulation of long non-coding RNAs during cardiac development. Biochim Biophys Acta. 2019;1862(10): 194435.","journal-title":"Biochim Biophys Acta"},{"key":"3477_CR20","doi-asserted-by":"crossref","unstructured":"Kontaraki JE, Marketou ME, Kochiadakis GE, Patrianakos A, Maragkoudakis S, Plevritaki A, et al. Long noncoding RNAs in peripheral blood mononuclear cells of hypertensive patients with heart failure with preserved ejection fraction in relation to their functional capacity. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2021;62(6):473\u20136.","DOI":"10.1016\/j.hjc.2021.02.011"},{"key":"3477_CR21","doi-asserted-by":"crossref","unstructured":"Jha S, Thasma Loganathbabu VK, Kumaran K, Krishnasamy G, Aruljothi KN. Long Non-Coding RNAs (lncRNAs) in Heart Failure: A Comprehensive Review. Non-coding RNA. 2023;10(1).","DOI":"10.3390\/ncrna10010003"},{"issue":"5","key":"3477_CR22","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/09168451.2019.1569499","volume":"83","author":"Y Shi","year":"2019","unstructured":"Shi Y, Chen C, Xu Y, Liu Y, Zhang H, Liu Y. LncRNA FENDRR promotes high-glucose-induced proliferation and angiogenesis of human retinal endothelial cells. Biosci Biotechnol Biochem. 2019;83(5):869\u201375.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"11","key":"3477_CR23","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/1440-1681.12997","volume":"45","author":"JE Kontaraki","year":"2018","unstructured":"Kontaraki JE, Marketou ME, Kochiadakis GE, Maragkoudakis S, Konstantinou J, Vardas PE, et al. The long non-coding RNAs MHRT, FENDRR and CARMEN, their expression levels in peripheral blood mononuclear cells in patients with essential hypertension and their relation to heart hypertrophy. Clin Exp Pharmacol Physiol. 2018;45(11):1213\u20137.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"3477_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14206","volume":"46","author":"M Farazandeh","year":"2022","unstructured":"Farazandeh M, Mahmoudabady M, Asghari AA, Niazmand S. Diabetic cardiomyopathy was attenuated by cinnamon treatment through the inhibition of fibro-inflammatory response and ventricular hypertrophy in diabetic rats. J Food Biochem. 2022;46(8): e14206.","journal-title":"J Food Biochem"},{"issue":"1","key":"3477_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","volume":"13","author":"L Meng","year":"2022","unstructured":"Meng L, Lin H, Huang X, Weng J, Peng F, Wu S. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA. Cell Death Dis. 2022;13(1):38.","journal-title":"Cell Death Dis"},{"key":"3477_CR26","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.2147\/IJGM.S338147","volume":"15","author":"X Zhao","year":"2022","unstructured":"Zhao X, Wang C, Liu M, Meng F, Liu K. LncRNA FENDRR Servers as a Possible Marker of Essential Hypertension and Regulates Human Umbilical Vein Endothelial Cells Dysfunction via miR-423-5p\/Nox4 Axis. Int J Gen Med. 2022;15:2529\u201340.","journal-title":"Int J Gen Med"},{"key":"3477_CR27","doi-asserted-by":"crossref","unstructured":"Dong B, Zhou B, Sun Z, Huang S, Han L, Nie H, et al. LncRNA-FENDRR mediates VEGFA to promote the apoptosis of brain microvascular endothelial cells via regulating miR-126 in mice with hypertensive intracerebral hemorrhage. Microcirculation (New York, NY : 1994). 2018;25(8):e12499.","DOI":"10.1111\/micc.12499"},{"issue":"12","key":"3477_CR28","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1080\/09168451.2020.1815170","volume":"84","author":"Y Wang","year":"2020","unstructured":"Wang Y, Sun H, Zhang J, Xia Z, Chen W. Streptozotocin-induced diabetic cardiomyopathy in rats: ameliorative effect of PIPERINE via Bcl2, Bax\/Bcl2, and caspase-3 pathways. Biosci Biotechnol Biochem. 2020;84(12):2533\u201344.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"Pt 1","key":"3477_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.130504","volume":"264","author":"YW Liao","year":"2024","unstructured":"Liao YW, Yu CC, Hsieh CW, Chao SC, Hsieh PL. Aberrantly downregulated FENDRR by arecoline elevates ROS and myofibroblast activation via mitigating the miR-214\/MFN2 axis. Int J Biol Macromol. 2024;264(Pt 1): 130504.","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"3477_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22887","volume":"35","author":"C Zhang","year":"2021","unstructured":"Zhang C, Yu H, Yang H, Liu B. Activation of PI3K\/PKB\/GSK-3\u03b2 signaling by sciadopitysin protects cardiomyocytes against high glucose-induced oxidative stress and apoptosis. J Biochem Mol Toxicol. 2021;35(10): e22887.","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"3477_CR31","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s11427-021-1982-8","volume":"65","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Li D, Dong X, Zhang X, Liu J, Peng L, et al. LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy. Sci China Life Sci. 2022;65(6):1198\u2013212.","journal-title":"Sci China Life Sci"},{"issue":"6","key":"3477_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166710","volume":"1869","author":"N Yang","year":"2023","unstructured":"Yang N, Wang M, Lin K, Wang M, Xu D, Han X, et al. Dectin-1 deficiency alleviates diabetic cardiomyopathy by attenuating macrophage-mediated inflammatory response. Biochim Biophys Acta. 2023;1869(6): 166710.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"3477_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107376","volume":"300","author":"Z Kang","year":"2024","unstructured":"Kang Z, Wang C, Shao F, Deng H, Sun Y, Ren Z, et al. The increase of long noncoding RNA Fendrr in hepatocytes contributes to liver fibrosis by promoting IL-6 production. J Biol Chem. 2024;300(6): 107376.","journal-title":"J Biol Chem"},{"key":"3477_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.622665","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang G, Yang Y, Ma H, Shi L, Jia W, Hao X, et al. LncRNA FENDRR Inhibits ox-LDL Induced Mitochondrial Energy Metabolism Disorder in Aortic Endothelial Cells via miR-18a-5p\/PGC-1\u03b1 Signaling Pathway. Front Endocrinol. 2021;12: 622665.","journal-title":"Front Endocrinol"},{"key":"3477_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.omtn.2019.05.027","volume":"17","author":"Z Yu","year":"2019","unstructured":"Yu Z, Zhao H, Feng X, Li H, Qiu C, Yi X, et al. Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells. Molecular Therapy Nucleic Acids. 2019;17:516\u201329.","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"3477_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12967-015-0672-0","volume":"13","author":"L Fang","year":"2015","unstructured":"Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, et al. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015;13:314.","journal-title":"J Transl Med"},{"issue":"3","key":"3477_CR37","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11845-021-02708-x","volume":"191","author":"N Du","year":"2022","unstructured":"Du N, Li M, Yang D. Hsa_circRNA_102541 regulates the development of atherosclerosis by targeting miR-296-5p\/PLK1 pathway. Ir J Med Sci. 2022;191(3):1153\u20139.","journal-title":"Ir J Med Sci"},{"key":"3477_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reth.2022.04.002","volume":"21","author":"S Che","year":"2022","unstructured":"Che S, Wu S, Yu P. Downregulated HDAC3 or up-regulated microRNA-296-5p alleviates diabetic retinopathy in a mouse model. Regenerative Therapy. 2022;21:1\u20138.","journal-title":"Regenerative Therapy"},{"issue":"2","key":"3477_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3104","volume":"35","author":"X Liu","year":"2019","unstructured":"Liu X, Wang Y, Zhang X, Zhang X, Guo J, Zhou J, et al. MicroRNA-296-5p promotes healing of diabetic wound by targeting sodium-glucose transporter 2 (SGLT2). Diabetes Metab Res Rev. 2019;35(2): e3104.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"3477_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41419-020-2316-4","volume":"11","author":"QQ Wu","year":"2020","unstructured":"Wu QQ, Liu C, Cai Z, Xie Q, Hu T, Duan M, et al. High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition. Cell Death Dis. 2020;11(3):160.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3477_CR41","first-page":"8909","volume":"13","author":"Y Bai","year":"2021","unstructured":"Bai Y, Liu F, Yang Z. CircRNA LRP6 promotes high-glucose induced proliferation and migration of vascular smooth muscle cells through regulating miR-545-3p\/HMGA1 signaling axis. Am J Transl Res. 2021;13(8):8909\u201320.","journal-title":"Am J Transl Res"},{"issue":"4","key":"3477_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/dna.2017.3957","volume":"37","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Chen L, Zhao Z, Wu Y, Zhong J, Wen G, et al. HMGA1 Mediated High-Glucose-Induced Vascular Smooth Muscle Cell Proliferation in Diabetes Mellitus: Association Between PI3K\/Akt Signaling and HMGA1 Expression. DNA Cell Biol. 2018;37(4):389\u201397.","journal-title":"DNA Cell Biol"},{"issue":"9","key":"3477_CR43","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/jama.2011.207","volume":"305","author":"E Chiefari","year":"2011","unstructured":"Chiefari E, Tanyola\u00e7 S, Paonessa F, Pullinger CR, Capula C, Iiritano S, et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA. 2011;305(9):903\u201312.","journal-title":"JAMA"},{"key":"3477_CR44","doi-asserted-by":"crossref","unstructured":"Yan S, Yao N, Li X, Sun M, Yang Y, Cui W, et al. The Association between the Differential Expression of lncRNA and Type 2 Diabetes Mellitus in People with Hypertriglyceridemia. International journal of molecular sciences. 2023;24(5).","DOI":"10.3390\/ijms24054279"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03477-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:42:47Z","timestamp":1748666567000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-025-03477-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3477"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03477-9","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Approval was obtained from the ethics committee of Yangpu Hospital, School of Medicine, Tongji University. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}